Pug puppies are prone to Chronic Degenerative Radiculomyelopathy (CDRM), a progressive neurological disorder that mainly affects the spinal cord and hind limbs, usually in dogs over seven years old. Although there is no cure, understanding the condition helps pet parents spot early signs and manage their dogs' well-being with compassion and informed care.
While Pugs are primarily impacted by CDRM, numerous other dog breeds also are susceptible because of genetic factors. Commonly affected breeds in the U.S. include:
CDRM is a neurological disease causing gradual deterioration of the spinal cord, mainly affecting rear limbs. Interestingly, affected dogs usually do not feel pain during the progression that leads to loss of mobility and paralysis. This condition is largely caused by mutations in the SOD1 gene, which interfere with the body's ability to defend nerve cells from oxidative damage, similar in effect to human motor neuron diseases like ALS.
In the U.S., veterinarians recognize this condition under the umbrella term "degenerative myelopathy," known for its genetic roots and slow progression.
Clinical signs vary from mild to severe and often include:
The disease stems primarily from a gene mutation affecting management of oxidative stress within nerve cells. These defective genes allow harmful free radicals to damage nerve tissue, leading to progressive degeneration. The SOD1 mutation is particularly present in breeds like Pugs, German Shepherds, and Boxers.
Responsible breeders and pet owners should consider genetic testing available through organizations such as the Orthopedic Foundation for Animals or University of Missouri to detect carriers and avoid breeding dogs likely to pass on the condition.
Screening dogs for the mutated gene is a fundamental step in preventing CDRM in future litters. Dogs found to be carriers or at higher genetic risk should not be bred. This practice helps promote healthier dog populations and reduces disease incidence. It is important to note that genetic tests indicate susceptibility but do not confirm active disease.
Typically affecting dogs aged 4 to 14 years, usually middle-aged to senior dogs, CDRM's initial signs may easily be mistaken for orthopedic problems. Owners might observe slight weakness on one side, minor paw dragging, or a change in gait. Early evaluation by a veterinarian or canine neurologist is critical to rule out treatable issues and secure an accurate diagnosis as soon as possible.
A thorough examination by a veterinarian includes physical and neurological assessments plus a detailed medical history. Referral to a canine neurologist for advanced testing might entail:
Unfortunately, there is no cure for Chronic Degenerative Radiculomyelopathy, and the outlook is generally unfavorable. The disease advances steadily, leading to loss of mobility and incontinence, severely affecting quality of life. When mobility becomes untenable and suffering risk increases, euthanasia may be the kindest choice.
Supportive therapies such as physical rehabilitation, hydrotherapy, and mobility aids (wheelchairs or harnesses) can help affected dogs maintain comfort and dignity as the disease progresses. Many American pet owners utilize veterinary rehabilitation specialists to preserve mobility for as long as possible.
A clear understanding of CDRM helps promote empathy and responsible care for Pugs and other breeds at risk. Ethical breeding combined with early detection and supportive management can positively impact these dogs' lives despite the disease's challenges.